Recombinant C1q variants modulate macrophage responses but do not activate the classical complement pathway. [PDF]
Espericueta V +4 more
europepmc +1 more source
Classical and alternative complement pathway activation in paracoccidioidomycosis.
The following study presents evidence of complement activation in paracoccidioidomycosis (PCM). Twenty-eight untreated patients were studied from endemic areas of Parana in southern Brazil. The activation of the classical pathway, evaluated by the C4d/C4 ratio, was significantly elevated in the patients compared to the control population (p < 0.005 ...
I T, de Messias, D, Mohren
openaire +1 more source
Cell-free IgG-aggregates in plasma of patients with chronic lymphocytic leukemia cause chronic activation of the classical complement pathway. [PDF]
Michelis R +8 more
europepmc +1 more source
Editorial: Role of complement activation in kidney diseases
Takashi Oda, Toshihiro Sawai
doaj +1 more source
Evolving understanding of Guillain-Barré syndrome pathophysiology and the central role of the classical complement pathway in axonal injury. [PDF]
Gorson KC.
europepmc +1 more source
Mesangial C1q Deposition in IgA Nephropathy: Does the Classical Complement Pathway Play an Independent Role? [PDF]
Gaggero G +3 more
europepmc +1 more source
Inhibition of the C1s Protease and the Classical Complement Pathway by 6-(4-Phenylpiperazin-1-yl)Pyridine-3-Carboximidamide and Chemical Analogs. [PDF]
Xu X +13 more
europepmc +1 more source
Dominant role of splenic marginal zone lipid rafts in the classical complement pathway against S. pneumoniae. [PDF]
Yang SW +13 more
europepmc +1 more source

